European journal of internal medicine
-
Eur. J. Intern. Med. · Jul 2020
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment.
Thrombocytopenia in cancer patients with an indication for anticoagulation poses a unique clinical challenge. There are guidelines for the setting of venous thromboembolism but not atrial fibrillation (AF). Evidence is lacking and current practice is unclear. ⋯ This study indicates what the widely accepted management strategies are. These strategies, and possibly others, should be assessed prospectively to ascertain effectiveness. The decision process is intricate and compatible with current venous thromboembolism guidelines.